Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrous sulphate add-on therapy for children with ADHD without iron deficiency or anemia
IRCT20120314009297N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ferrous sulfate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Strengths and Difficulties Questionnaire, Rutter and Conners' Parent Rating Scale and 11 more. Started Mar 2017; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20120314009297N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120314009297N3.